REPROCELL
ReproCELL Incorporated is primarily engaged in the development of stem cell technologies. The Company operates its business in two segments. The IPS Cell segment deals with regenerative medicine focused on Human ES (embryonic stem) cells and human iPS (induced pluripotent stem) cells. This segment manufactures research reagents used in human ES / iPS cell research, such as culture fluid, peeling liquid, frozen preservation solution, coating agents and antibody. The Clinical Testing segment clini... cal testing services that is required by hematopoietic stem cell transplantation and organ transplantation. On February 10, 2014, it established a Kanagawa-based wholly owned subsidiary. On June 30, 2014, it acquired 85.2% interests in Reinnervate Limited, a UK-based company. On July 1, 2014, it fully acquired Reinnervate Limited. In July, 2014, it acquired BioServe Biotechnologies, Ltd. On September 2, 2014, it completed the acquisition of BioServe Biotechnologies, Ltd.
REPROCELL
Industry:
Biotechnology Health Care Manufacturing Test And Measurement
Founded:
2003-01-01
Address:
Yokohama, Kanagawa, Japan
Country:
Japan
Website Url:
http://www.reprocell.com
Total Employee:
51+
Status:
Active
Contact:
(814) 547-5388
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Global Site Tag Microsoft Exchange Online Office 365 Mail
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-04-25 | BioServe Biotechnologies (India) | BioServe Biotechnologies (India) acquired by ReproCELL | N/A |
| 2015-11-24 | Biopta | Biopta acquired by ReproCELL | N/A |
| 2014-08-05 | ReInnervate | ReInnervate acquired by ReproCELL | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-04-25 | Symic Biomedical | ReproCELL investment in Series C - Symic Biomedical | 11 M USD |
| 2016-12-05 | Kringle Pharma | ReproCELL investment in Venture Round - Kringle Pharma | 610 M JPY |
Official Site Inspections
http://www.reprocell.com Semrush global rank: 1.46 M Semrush visits lastest month: 18.72 K
- Host name: 109.108.148.102.srvlist.ukfast.net
- IP address: 109.108.148.102
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "ReproCELL"
About REPROCELL
Feb 4, 2016 Over the last decade, REPROCELL has evolved its global infrastructure, corporate organization, and strategy. By leveraging our knowledge base of stem cell technologies, …See details»
REPROCELL Global
REPROCELL can help you drive your next clinical MSC project to success and ensure compliancy with regulatory agencies. Clinical MSCs. Human Tissue Pharmacology. Human …See details»
ReproCELL - Crunchbase Company Profile & Funding
ReproCELL Incorporated is primarily engaged in the development of stem cell technologies. The Company operates its business in two segments. The IPS Cell segment deals with …See details»
Our services and products for stem cells and drug discovery
Working together as a global organization, REPROCELL provides an integrated workflow of services and products powering translational research with stem cells and discovery …See details»
Improving human health through biomedical innovation and
Organization (CRO) that specializes in customized drug discovery assays using live human tissues secured in accordance with ethical guidelines .of governmental and medical agencies. …See details»
ReproCELL - Funding, Financials, Valuation & Investors - Crunchbase
Jun 5, 2024 ReproCELL has raised 1 round. This was a Grant round raised on Jun 5, 2024. ReproCELL is registered under the ticker TYO:4978 . ReproCELL is funded by Maryland Stem …See details»
Drug Discovery & Clinical Services - REPROCELL
Jan 14, 2018 Our GLP contract research services in human tissues have been trusted by the top pharma and biotech companies since 2002. We provide data that is highly predictive of in vivo …See details»
ReproCELL Incorporated | J-Startup
REPROCELL, founded in 2003, has extensive and accumulated capabilities in iPS cells. As a pioneer with a global outreach in USA, UK, and India, we continue to drive science and …See details»
REPROCELL Company Profile - Office Locations, Competitors
Oct 29, 2024 REPROCELL is a company engaged in the development of stem cell technologies. It supports stem cell research and pre-clinical drug development workflow. REPROCELL's …See details»
REPROCELL - LinkedIn
REPROCELL supports nearly the entire workflow of stem cell research and pre-clinical drug development. Our unique portfolio includes access to human tissues (BioServe) and human …See details»
Reprocell Inc. | Insights
Contract Research Organization-CRO; Pharmaceuticals; Distributors; Biotechnology. Drug Discovery Technologies; Gene Therapy, Cell Therapy; Research, Analytical Equipment & …See details»
ReproCELL - Overview, News & Similar companies | ZoomInfo.com
Jun 13, 2023 Who is ReproCELL. Founded in 2003, ReproCELL operates as a stem cell research company, offering stem cell reagents, including RNA reprogramming, small …See details»
REPROCELL - YouTube
REPROCELL was also the first company to offer iPSC-derived human cardiomyocytes, hepatocytes and neuronal cells for research applications. ... Across the entire organization, …See details»
REPROCELL USA Products & Services for Drug Discovery
The REPROCELL portfolio includes access to human tissues and predictive drug discovery custom services. X. This site uses cookies to provide and improve your shopping experience. …See details»
Investor Relations - REPROCELL
REPROCELL’s Personal iPS service allows clients to generate and store iPSCs for use in future regenerative medicine treatments. Currently, iPSCs are being investigated for the treatment of …See details»
ReproCell Inc, 4978:TYO profile - FT.com - Financial Times
Mar 19, 2025 Year on year ReproCell Inc had revenues fall -17.83% from 2.95bn to 2.43bn, though the company grew net income from a loss of 305.31m to a smaller loss of 31.41m. …See details»
REPROCELL provides products and services across the entire drug ...
REPROCELL’s human tissue technology predicts clinical success by using the closest possible model of drug behavior in humans REPROCELL offers contract laboratory services to …See details»
FREQUENTLY ASKED QUESTIONS - REPROCELL
REPROCELL’s BioServe* Global Biorepository provides leading academic and industry researchers with access to over 600,000 human DNA, serum and tissue samples linked to …See details»
ReproCELL, Inc. (ReproCELL, Inc.) - 药物管线_专利_临床试验_投融 …
了解ReproCELL, Inc. (ReproCELL, Inc.)公司的药物管线，治疗领域，技术平台，以及它的2项临床试验, 17篇新闻和61篇文献，疾病领域:感染，技术平台:预防性疫苗，mRNA疫苗，药物:cross …See details»
Product Catalog - REPROCELL
REPROCELL is a manufacturer and vendor of cells and products for stem cell research and 3D cell culture. Our product catalog currently serves territories covered by REPROCELL USA …See details»